跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,956 条关于
“HRR genes”
全部
8,956
临床试验
4,902
药物
1,478
机构
30
资讯
2,546
去年
LODESTAR Study Marks First Tumor-Agnostic Trial of PARP Inhibitor Rucaparib in HRR Gene Variants
去年
Cabazitaxel Shows Efficacy in Metastatic Castration-Resistant Prostate Cancer with Osseous Metastases
去年
Genomic Scarring Score Predicts PARP Inhibitor Response in NSCLC
去年
ctDNA Analysis Reveals Mechanisms of PARP Inhibitor Resistance in Prostate Cancer
2年前
Lynparza Shows Promise as Non-Hormonal Therapy for Prostate Cancer with HRR Mutations
2年前
Saruparib Shows Promise in HRR-Deficient Breast Cancer
去年
STAMPEDE2 Trial to Evaluate Niraparib and Abiraterone Combination in Metastatic Hormone-Sensitive Prostate Cancer
6个月前
Pfizer's Talzenna Shows Significant Benefit in Hormone-Sensitive Prostate Cancer Trial
去年
AMPLITUDE Trial Shows Niraparib Combination Reduces Cancer Progression Risk by 37% in HRR-Mutant Metastatic Prostate Cancer
去年
Real-World Data Shows Olaparib Benefits mCRPC Patients with HRR Mutations
第 1 页,共 255 页
上一页
下一页